Jennifer Bogert

474 total citations
10 papers, 270 citations indexed

About

Jennifer Bogert is a scholar working on Physiology, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Jennifer Bogert has authored 10 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 4 papers in Molecular Biology and 4 papers in Psychiatry and Mental health. Recurrent topics in Jennifer Bogert's work include Alzheimer's disease research and treatments (7 papers), Dementia and Cognitive Impairment Research (4 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers). Jennifer Bogert is often cited by papers focused on Alzheimer's disease research and treatments (7 papers), Dementia and Cognitive Impairment Research (4 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers). Jennifer Bogert collaborates with scholars based in United States, Belgium and Sweden. Jennifer Bogert's co-authors include H. Robert Brashear, Johannes Streffer, Sebastiaan Engelborghs, Maarten Timmers, Luc Van Nueten, Luc Tritsmans, Nzeera Ketter, Jianing Di, Ina Tesseur and Alberto Russu and has published in prestigious journals such as Journal of Affective Disorders, Neurobiology of Aging and Journal of Alzheimer s Disease.

In The Last Decade

Jennifer Bogert

10 papers receiving 265 citations

Peers

Countries citing papers authored by Jennifer Bogert

Since Specialization

Citations

This map shows the geographic impact of Jennifer Bogert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Bogert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Bogert more than expected).

Fields of papers citing papers by Jennifer Bogert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Bogert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Bogert. The network helps show where Jennifer Bogert may publish in the future.

Co-authorship network of co-authors of Jennifer Bogert

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Bogert. A scholar is included among the top collaborators of Jennifer Bogert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Bogert. Jennifer Bogert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	A randomized, multicenter, crossover psychometric evaluation study of an iPad-administered cognitive test battery in participants with major depressive disorder who responded to treatment with oral antidepressants 2021 ·Journal of Affective Disorders ·Jennifer Bogert, Hany Rofael, (unknown), (unknown), (unknown), Daniel Wang, Judith Jaeger, Vaibhav A. Narayan, Wayne C. Drevets, Randall L. Morrison	1
2	Long-term safety and tolerability of atabecestat (JNJ-54861911), an oral BACE1 inhibitor, in early Alzheimer’s disease spectrum patients: a randomized, double-blind, placebo-controlled study and a two-period extension study 2020 ·Alzheimer s Research & Therapy ·Gerald Novak, Johannes Streffer, Maarten Timmers, David Henley, H. Robert Brashear, Jennifer Bogert, Alberto Russu, Luc Janssens, Ina Tesseur, Luc Tritsmans, Luc Van Nueten, Sebastiaan Engelborghs	73
3	Relevance of the interplay between amyloid and tau for cognitive impairment in early Alzheimer's disease 2019 ·Neurobiology of Aging ·Maarten Timmers, Ina Tesseur, Jennifer Bogert, Henrik Zetterberg, Kaj Blennow, Anne Börjesson‐Hanson, Miquel Baquero, Merçé Boada, Christopher Randolph, Luc Tritsmans, Luc Van Nueten, Sebastiaan Engelborghs, Johannes Streffer	28
4	Evaluating Potential QT Effects of JNJ‐54861911, a BACE Inhibitor in Single‐ and Multiple‐Ascending Dose Studies, and a Thorough QT Trial With Additional Retrospective Confirmation, Using Concentration‐QTc Analysis 2018 ·The Journal of Clinical Pharmacology ·Maarten Timmers, Vikash Sinha, Börje Darpö, Brian P. Smith, (unknown), (unknown), Georg Ferber, Johannes Streffer, Alberto Russu, Luc Tritsmans, Bhavna Solanki, Jennifer Bogert, Luc Van Nueten, Giacomo Salvadore, Partha Nandy	7
5	Clinical Evaluation of Amyloid-Related Imaging Abnormalities in Bapineuzumab Phase III Studies 2018 ·Journal of Alzheimer s Disease ·H. Robert Brashear, Nzeera Ketter, Jennifer Bogert, Jianing Di, Stephen Salloway, Reisa A. Sperling	26
6	BACE1 Dynamics Upon Inhibition with a BACE Inhibitor and Correlation to Downstream Alzheimer’s Disease Markers in Elderly Healthy Participants 2017 ·Journal of Alzheimer s Disease ·Maarten Timmers, Soraia Barão, Bianca Van Broeck, Ina Tesseur, (unknown), (unknown), Jennifer Bogert, Leslie M. Shaw, Sebastiaan Engelborghs, Dieder Moechars, Marc Mercken, Luc Van Nueten, Luc Tritsmans, Bart De Strooper, Johannes Streffer	26
7	Central Review of Amyloid-Related Imaging Abnormalities in Two Phase III Clinical Trials of Bapineuzumab in Mild-To-Moderate Alzheimer’s Disease Patients 2017 ·Journal of Alzheimer s Disease ·Nzeera Ketter, H. Robert Brashear, Jennifer Bogert, Jianing Di, Y Miaux, Achim Gass, Derk D. Purcell, Frederik Barkhof, H. Michael Arrighi	50
8	Impact of frequent cerebrospinal fluid sampling on Aβ levels: systematic approach to elucidate influencing factors 2016 ·Alzheimer s Research & Therapy ·Bianca Van Broeck, Maarten Timmers, Steven Ramael, Jennifer Bogert, Leslie M. Shaw, Marc Mercken, (unknown), Luc Van Nueten, Sebastiaan Engelborghs, Johannes Streffer	10
9	Disease Burden Associated with Geographic Atrophy Secondary to Age-related Macular Degeneration 2016 ·(unknown), (unknown), Jennifer Bogert, Tom Chang, (unknown), Ross D. Crosby, Susan D. Mathias, Allen C. Ho	1
10	Profiling the dynamics of CSF and plasma Aβ reduction after treatment with JNJ‐54861911, a potent oral BACE inhibitor 2016 ·Alzheimer s & Dementia Translational Research & Clinical Interventions ·Maarten Timmers, Bianca Van Broeck, Steven Ramael, (unknown), (unknown), Alberto Russu, Jennifer Bogert, Hans Stieltjes, Leslie M. Shaw, Sebastiaan Engelborghs, Dieder Moechars, Marc Mercken, Enchi Liu, Vikash Sinha, John A. Kemp, Luc Van Nueten, Luc Tritsmans, Johannes Streffer	48

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact